| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14a5814322ef4614aa746655eb9f691e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 |
| filingDate |
2000-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_728a2d4fba17dd2b03166d05fa753796
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3b38ccbc3f4cbfe15bc19295daffa52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9d5bcf6d9107a6770375456ae419431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c04f488cfd15ccb4cfe9438c7a95703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d940524c3cc329bd5a1d92b90e06a2e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fe7f89b24525207dbaa51ce37ca3f8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_049073a162a6ea158568cd123e6891c0 |
| publicationDate |
2003-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1317261-A1 |
| titleOfInvention |
Preparation for treating diseases of bone tissues |
| abstract |
The present invention refers to an considerably improved medicinal preparation and its synthesising method, in particular for allowing to affect the osteoreparative process due to stimulation of the prolific and functional acitivity of osteoblasts without risk of development of the immunologic conflict reactions. According to the invnetion it is provided a medicinal combined preparation for treating diseases of bone tissue ocntaining at least a medicinal component, especially having anti-inflammatory and/or anti-bacterial properties and nano-sized crystalline hydroxyapatitie having average dimensions with a length equal to 0.06 νm 50 %, a width equal to 0.015 νm 50 % and a thickness equal to a single transmission of crystalline lattice of the hydroxyapatite, in particular to 0.00068 νm or 0.000814 νm depending on direction of the symmetry axis of the crystalline cell. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011038905-A2 |
| priorityDate |
2000-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |